Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital

被引：0
|
作者：
Roeland, Eric [1 ]
Hwang, Michael [1 ]
机构：
[1] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
563
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: A prospective randomized trial
    Ripamonti, C
    Mercadante, S
    Groff, L
    Zecca, E
    De Conno, F
    Casuccio, A
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 19 (01) : 23 - 34
  • [22] Covered Wallstent for Palliation of Malignant Biliary Obstruction: Retrospective Single Center Study of 103 Patients
    Ornellas, Laura
    Stefanidis, Gerasimos
    Gelrud, Andres
    Kelleher, T. Barry
    Chuttani, Ram
    Pleskow, Douglas
    GASTROINTESTINAL ENDOSCOPY, 2006, 63 (05) : AB286 - AB286
  • [23] MEDICAL MANAGEMENT OF MALIGNANT INOPERABLE BOWEL OBSTRUCTION (MIOB) IN A HOME CARE ASSISTANCE SETTING: A SINGLE-INSTITUTION EXPERIENCE
    Liguori, Simona
    Orlando, Vito
    ANNALS OF ONCOLOGY, 2004, 15 : 105 - 105
  • [24] Clinician-reported changes in octreotide prescribing for malignant bowel obstruction as a result of an adequately powered phase III study: A transnational, online survey
    Campbell, Rachel
    McCaffrey, Nikki
    Brown, Linda
    Agar, Meera R.
    Clark, Katherine
    Currow, David C.
    PALLIATIVE MEDICINE, 2018, 32 (08) : 1363 - 1368
  • [25] Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer
    Peng, Xingang
    Wang, Peige
    Li, Shikuan
    Zhang, Guangyong
    Hu, Sanyuan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [26] Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer
    Xingang Peng
    Peige Wang
    Shikuan Li
    Guangyong Zhang
    Sanyuan Hu
    World Journal of Surgical Oncology, 13
  • [27] Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide
    McCaffrey, Nikki
    Asser, Tegan
    Fazekas, Belinda
    Muircroft, Wendy
    Agar, Meera
    Clark, Katherine
    Eckermann, Simon
    Lee, Jessica
    Joshi, Rohit
    Allcroft, Peter
    Sheehan, Caitlin
    Currow, David C.
    BMC CANCER, 2020, 20 (01)
  • [28] Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide
    Nikki McCaffrey
    Tegan Asser
    Belinda Fazekas
    Wendy Muircroft
    Meera Agar
    Katherine Clark
    Simon Eckermann
    Jessica Lee
    Rohit Joshi
    Peter Allcroft
    Caitlin Sheehan
    David C. Currow
    BMC Cancer, 20
  • [29] EDMOND: A FEASIBILITY STUDY OF ELEMENTAL DIET AS AN ALTERNATIVE TO PARENTERAL NUTRITION FOR OVARIAN CANCER PATIENTS WITH INOPERABLE MALIGNANT BOWEL OBSTRUCTION
    Michael, Agnieszka
    Allan, Lindsey
    Bennett-Eastely, Kate
    Herbertson, Rebecca
    Skene, Simon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A85 - A85
  • [30] To operate or not to operate?: Preoperative factors associated with unsuccessful palliation following surgery for malignant bowel obstruction in patients with recurrent ovarian cancer
    Byrne, Maureen
    Boerner, Thomas
    Miller, Kathryn
    Leitao, Mario
    Broach, Vance
    Roche, Kara Long
    Zivanovic, Oliver
    Sonoda, Yukio
    Chi, Dennis
    Gardner, Ginger
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S148 - S149
12345